Trajectory of Cardiometabolic Disease-Related Hospitalizations Before and After Dementia Diagnosis: A Matched Cohort

Sakura Sakakibara1, Abigail Dove1, Michelle M Dunk1

  • 1Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Insights

Hospitalizations for cardiometabolic diseases (CMDs) increase years before dementia diagnosis and decrease afterward. Factors like male sex, smoking, obesity, and hypertension worsen this trend in dementia patients.

Area of Science:

  • Gerontology
  • Neurology
  • Cardiology

Background:

  • Dementia significantly increases healthcare utilization.
  • Cardiometabolic diseases (CMDs) frequently co-occur with dementia.
  • The relationship between dementia progression and CMD-related hospitalizations is not well understood.

Purpose of the Study:

  • To analyze the pattern of hospitalizations related to cardiometabolic diseases (CMDs) before and after dementia diagnosis.
  • To identify factors associated with CMD-related hospitalizations in individuals with dementia.

Main Methods:

  • A matched cohort study was conducted using the Swedish Twin Registry.
  • 1657 participants with incident dementia were matched with 1657 dementia-free controls.
  • Participants were followed for up to 20 years, analyzing CMD-related hospitalizations using Poisson regression and generalized estimating equation models.

Main Results:

  • CMD-related hospitalizations increased from 4 years prior to dementia diagnosis and decreased 3 years post-diagnosis.
  • Individuals with dementia experienced more CMD-related hospitalizations and longer hospital stays in the 5 years preceding diagnosis.
  • Male sex, smoking, obesity, and hypertension were linked to increased CMD-related hospitalizations in dementia patients.

Conclusions:

  • Hospitalization patterns for CMDs change significantly during dementia development.
  • Increased healthcare burden, indicated by CMD-related hospitalizations, can manifest even before a dementia diagnosis.
  • CMD-related hospitalizations may serve as an early indicator for future dementia onset.
Abstract

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
70
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128